The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
Open accessAbstract
Severe community-acquired pneumonia (CAP) requiring intensive care unit admission is associated with significant acute and long-term morbidity and mortality. We hypothesized that downregulation of systemic and pulmonary inflammation with prolonged low-dose methylprednisolone treatment would accelerate pneumonia resolution and improve clinical outcomes. This double-blind, randomized, placebo-controlled clinical trial recruited adult patients within 72–96 h of hospital presentation. Patients were randomized in 1:1 ratio; an intravenous 40 mg loading bolus was followed by 40 mg/day through day 7 and progressive tapering during the 20-day treatment course. Randomization was stratified by site and need for mechanical ventilation (MV) at the time of randomization. Outcomes included a primary endpoint of 60-day all-cause mortality and secondary endpoints of morbidity and mortality up to 1 year of follow-up. Between January 2012 and April 2016, 586 patients from 42 Veterans Affairs Medical Centers were randomized, short of the 1420 target sample size because of low recruitment. 584 patients were included in the analysis. There was no significant difference in 60-day mortality between the methylprednisolone and placebo arms (16% vs. 18%; adjusted odds ratio 0.90, 95% CI 0.57–1.40). There were no significant differences in secondary outcomes or complications. In patients with severe CAP, prolonged low-dose methylprednisolone treatment did not significantly reduce 60-day mortality. Treatment was not associated with increased complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Self-citationSerial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862
Long-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
Cited by
Hydrocortisone in Severe Community-Acquired Pneumonia
Dequin, P.-F., Meziani, F., Quenot, J.-P., Kamel, T., Ricard, J.-D., Badie, J., Reignier, J., Heming, N., Plantefève, G., Souweine, B., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2215145 · Cited by 468
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I., Torres, A., Nagavci, B., Aliberti, S., Antonelli, M., Bassetti, M., Bos, L. D., Chalmers, J. D., Derde, L., de Waele, J., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07033-8 · Cited by 316
Self-citation
Metadata
- Authors
- Meduri, G. U., Shih, M.-C., Bridges, L., Martin, T. J., El-Solh, A., Seam, N., Davis-Karim, A., Umberger, R., Anzueto, A., Sriram, P., Lan, C., Restrepo, M. I., Guardiola, J. J., Buck, T., Johnson, D. P., Suffredini, A., Bell, W. A., Lin, J., Zhao, L., Uyeda, L., Nielsen, L., Huang, G. D., the ESCAPe Study Group, Bashir, K., Ioachimescu, O., Buck, T., Johnson, D., El Solh, A., Frye, M., Panos, R., Shatat, M., Gray, E., Smith, B., Kung, M., Cutrell, J., Bedimo, R., Sriram, P., Lan, C., Rastogi, P., Callaghan, J., Hage, C., Plautz, M., Schaninger, T., Greenberg, R., Specht, L., Sassoon, C., Guardiola, J., Ramirez, J., Muthiah, M. P., Schein, R., Antonesu-Turcu, A., Rice, K., Youness, H., Morrow, L., Kuschner, W., Pineda, L., Robbins, R. A., Camhi, S., Jankowich, M., Ahmed, W., Martin, T., Horowitz, M., Nord, J., Elstad, M., Restrepo, M. I., Anzueto, A., Bigby, T., Rodriguez-Cintron, W., Fan, V., Kaul, P., Habib, M., Seam, N., & Hoo, G. S.
- Venue
- Intensive Care Medicine
- Published
- 2022-05-13
- Volume
- 48
- Issue
- 8
- Pages
- 1009-1023
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W4283158129
- Cited by
- 220
- References
- 4
- FWCI
- 28.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. https://app.cochat.ai/papers/10.1007/s00134-022-06684-3
- The paper
- Meduri, G. U., Shih, M.-C., Bridges, L., Martin, T. J., El-Solh, A., Seam, N., Davis-Karim, A., Umberger, R., Anzueto, A., Sriram, P., Lan, C., Restrepo, M. I., Guardiola, J. J., Buck, T., Johnson, D. P., Suffredini, A., Bell, W. A., Lin, J., Zhao, L., . . . Hoo, G. S. (2022). Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Medicine. https://doi.org/10.1007/s00134-022-06684-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.